annb0t
Top 20
Mesoblast Limited
Mesoblast Financial and Operational Highlights for Quarter Ended March 31, 2023
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the third quarter ended March 31, 2023.
Financial Highlights
Successful completion of a global private placement primarily to Mesoblastâs existing major US, UK, and Australian shareholders raisi...
>>> Read more: Appendix 4C Quarterly Activity Report
Mesoblast Financial and Operational Highlights for Quarter Ended March 31, 2023
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the third quarter ended March 31, 2023.
Financial Highlights
Successful completion of a global private placement primarily to Mesoblastâs existing major US, UK, and Australian shareholders raisi...
>>> Read more: Appendix 4C Quarterly Activity Report
